v3.26.1
HPI - Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net income $ 130,122 $ 119,221
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 156,591 146,084
Amortization of lease incentives and acquisition-related intangible assets and liabilities 1,648 1,122
Share-based compensation expense 7,400 6,277
Net credit losses on operating lease receivables 1,857 139
Accrued interest on mortgages and notes receivable (816) (496)
Amortization of debt issuance costs 3,081 2,821
Amortization of cash flow hedges (131) (124)
Amortization of mortgages and notes payable fair value adjustments 175 56
Losses on debt extinguishment 60 0
Net gains on disposition of property (95,987) (82,215)
Equity in earnings of unconsolidated affiliates (2,571) (1,625)
Distributions of earnings from unconsolidated affiliates 4,104 3,516
Changes in operating assets and liabilities:    
Accounts receivable 710 2,841
Prepaid expenses and other assets 260 (4,904)
Accrued straight-line rents receivable (16,769) (6,004)
Accounts payable, accrued expenses and other liabilities (1,658) (23,854)
Net cash provided by operating activities 188,076 162,855
Investing activities:    
Investments in acquired real estate and related intangible assets, net of cash acquired (309,838) (137,828)
Investments in development in-process (1,731) (593)
Investments in tenant improvements and deferred leasing costs (84,601) (61,919)
Investments in building improvements (26,785) (21,551)
Net proceeds from disposition of real estate assets 297,533 137,779
Distributions of capital from unconsolidated affiliates 55,948 3,742
Investments in mortgages and notes receivable 0 (1,577)
Repayments of mortgages and notes receivable 0 6,333
Investments in and advances to unconsolidated affiliates (33,646) (16,681)
Changes in earnest money deposits 0 10,000
Changes in other investing activities 1,422 139
Net cash used in investing activities (101,698) (82,156)
Financing activities:    
Dividends on Common Stock (110,112) (107,738)
Redemptions/repurchases of Preferred Stock (60) (2,095)
Redemptions of Common Units (24) (10)
Dividends on Preferred Stock (1,148) (1,207)
Distributions to noncontrolling interests in the Operating Partnership (2,017) (2,151)
Distributions to noncontrolling interest in consolidated affiliates (4,891) (160)
Contributions from noncontrolling interests in consolidated affiliates 197,202 0
Proceeds from the issuance of Common Stock 655 2,191
Costs paid for the issuance of Common Stock (455) (324)
Repurchase of shares related to tax withholdings (1,865) (2,009)
Borrowings on revolving credit facility 203,000 237,000
Repayments of revolving credit facility (228,000) (194,000)
Borrowings on mortgages and notes payable 20,000 0
Repayments of mortgages and notes payable (34,396) (3,865)
Payments for debt issuance costs and other financing activities (1,286) 0
Net cash provided by/(used in) financing activities 36,603 (74,368)
Net increase in cash and cash equivalents and restricted cash 122,981 6,331
Cash and cash equivalents and restricted cash at beginning of the period 43,049 33,677
Cash and cash equivalents and restricted cash at end of the period 166,030 40,008
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents at end of the period 145,377 21,193
Restricted cash at end of the period 20,653 18,815
Supplemental disclosure of cash flow information:    
Cash paid for interest, net of amounts capitalized 71,069 71,400
Supplemental disclosure of non-cash investing and financing activities:    
Conversions of Common Units to Common Stock 700 0
Changes in accrued capital expenditures [1] 19,084 (2,218)
Write-off of fully depreciated real estate assets 44,862 54,439
Write-off of fully amortized leasing costs 15,376 25,199
Write-off of fully amortized debt issuance costs 1,097 0
Adjustment of noncontrolling interests in the Operating Partnership to fair value 8,509 927
Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities $ 64,100 $ 50,700
[1] Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities as of June 30, 2026 and 2025 were $64.1 million and $50.7 million, respectively.